Mutations in SETD2 cause a novel overgrowth condition
A Luscan, I Laurendeau, V Malan… - Journal of medical …, 2014 - jmg.bmj.com
Background Overgrowth conditions are a heterogeneous group of disorders characterised
by increased growth and variable features, including macrocephaly, distinctive facial …
by increased growth and variable features, including macrocephaly, distinctive facial …
DNA methylation episignatures: insight into copy number variation
L der Laan, K Rooney, TMA Trooster… - …, 2022 - Taylor & Francis
In this review we discuss epigenetic disorders that result from aberrations in genes linked to
epigenetic regulation. We describe current testing methods for the detection of copy number …
epigenetic regulation. We describe current testing methods for the detection of copy number …
Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association
This update expands the prior scientific statement on the relevance of genetics and
genomics for the prevention and treatment of CVDs. 2 In the earlier report, we focused on …
genomics for the prevention and treatment of CVDs. 2 In the earlier report, we focused on …
Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities
The goal of sequencing the entire human genome for $1000 is almost in sight. However, the
total costs including DNA sequencing, data management, and analysis to yield a clear data …
total costs including DNA sequencing, data management, and analysis to yield a clear data …
[HTML][HTML] Artificial intelligence (AI)-assisted exome reanalysis greatly aids in the identification of new positive cases and reduces analysis time in a clinical diagnostic …
TD O'Brien, NE Campbell, AB Potter, JH Letaw… - Genetics in …, 2022 - Elsevier
Purpose Artificial intelligence (AI) and variant prioritization tools for genomic variant analysis
are being rapidly developed for use in clinical diagnostic testing. However, their clinical …
are being rapidly developed for use in clinical diagnostic testing. However, their clinical …
Frequent genes in rare diseases: panel‐based next generation sequencing to disclose causal mutations in hereditary neuropathies
MF Dohrn, N Glöckle, L Mulahasanovic… - Journal of …, 2017 - Wiley Online Library
Hereditary neuropathies comprise a wide variety of chronic diseases associated to more
than 80 genes identified to date. We herein examined 612 index patients with either a …
than 80 genes identified to date. We herein examined 612 index patients with either a …
A complex V ATP5A1 defect causes fatal neonatal mitochondrial encephalopathy
AI Jonckheere, GH Renkema, M Bras… - Brain, 2013 - academic.oup.com
Whole exome sequencing is a powerful tool to detect novel pathogenic mutations in patients
with suspected mitochondrial disease. However, the interpretation of novel genetic variants …
with suspected mitochondrial disease. However, the interpretation of novel genetic variants …
Targeted next-generation sequencing of deafness genes in hearing-impaired individuals uncovers informative mutations
Purpose: Targeted next-generation sequencing provides a remarkable opportunity to
identify variants in known disease genes, particularly in extremely heterogeneous disorders …
identify variants in known disease genes, particularly in extremely heterogeneous disorders …
Exome sequencing as a diagnostic tool for pediatric‐onset ataxia
Ataxia demonstrates substantial phenotypic and genetic heterogeneity. We set out to
determine the diagnostic yield of exome sequencing in pediatric patients with ataxia without …
determine the diagnostic yield of exome sequencing in pediatric patients with ataxia without …
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer …
Abstract We describe Exome Cancer Test v1. 0 (EXaCT-1), the first New York State-
Department of Health-approved whole-exome sequencing (WES)-based test for precision …
Department of Health-approved whole-exome sequencing (WES)-based test for precision …